U.S., Aug. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07111117) titled 'Comparison of 18F Labeled Analog of MIBG (18F-MFBG) PET/CT and 123I-MIBG SPECT in Pediatric Patients With Neuroblastoma.' on Jan. 10, 2024.
Brief Summary: The goals of the NEUROBLASTOTEP trial is to compare the diagnostics performance of a the 18F-metafluorobenzylguanidine (18F-MFBG) Positron Emission Tomography / Computed Tomography scan (PET/CT) compared to 123I-metaiodobenzylguanidine (123I-MIBG scintigraphy (current gold standard) for imaging in neuroblastoma.
Study Start Date: March 01, 2026
Study Type: INTERVENTIONAL
Condition:
Neuroblastoma
Intervention:
PROCEDURE: 18F-MFBG PET/CT imaging
Participants will receive the 1...